Skip to content
AiONAiON
Medical directoryActive ingredient

Exenatide

The first GLP-1 receptor agonist to be approved, derived from the venom of the Gila monster. It mimics the action of the hormone GLP-1 to stimulate insulin secretion and regulate appetite. Given daily or weekly.

Institutional endorsement by Clínica Evolution

Medical guides

Keep reading

This entry is for information. Your case requires an individual medical assessment.